Edition:
United States

Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

194.00ILa
10:24am EST
Change (% chg)

16.80 (+9.48%)
Prev Close
177.20
Open
180.00
Day's High
196.00
Day's Low
180.00
Volume
1,619,994
Avg. Vol
863,471
52-wk High
368.80
52-wk Low
110.50

PLX.TA

Chart for PLX.TA

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.47
Market Cap(Mil.): ₪185.09
Shares Outstanding(Mil.): 99.93
Dividend: --
Yield (%): --

Financials

  PLX.TA Industry Sector
P/E (TTM): -- 45.12 30.76
EPS (TTM): -1.35 -- --
ROI: -72.58 -1.32 14.89
ROE: -- -0.98 16.30

Earnings vs. Estimates